The Jordan Company Announces Agreement To Acquire Arclin From Lone Star
08/16/21, 4:25 PM
Arclin, Inc. ("Arclin" or the "Company"), a chemistry-based provider of highly technical, engineered products for the residential building products market and other industries, today announced that it has signed a definitive agreement whereby an affiliate of The Jordan Company, L.P. ("TJC") will acquire Arclin from funds affiliated with Lone Star Funds. Arclin's senior management team, led by CEO Brad Bolduc, will maintain a significant equity stake in Arclin and continue to lead the Company going forward. While the terms of the transaction were not disclosed, the transaction is expected to close in the third quarter of 2021.
Company Info
Company info
About The Jordan Company TJC (www.thejordancompany.com), founded in 1982, is a middle-market private equity firm that has managed funds with original capital commitments in excess of $15 billion and a 39-year track record of investing in and contributing to the growth of many businesses across a wide range of industries including Healthcare & Consumer; Industrials; Technology, Telecom & Utilities; and Transportation & Logistics. The senior investment team has been investing together for over 20 years and is supported by the Operations Management Group, which was established in 1988 to initiate and support operational improvements in portfolio companies. Headquartered in New York, TJC also has offices in Chicago and Stamford.